🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro pen vs compounded vial - pros and cons? — looking for input Page 3

Mounjaro pen vs compounded vial - pros and cons? — looking for input

nick_newbie Tue, Jul 9, 2024 at 10:50 AM 43 replies 2,583 viewsPage 3 of 9
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Jul 9, 2024 at 9:52 PM#11
Dr.LeslieOBGYN said:
Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.

33 6kevin_tulsa, Dr.PainCLE, mike_mealprep and 30 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Jul 10, 2024 at 3:42 AM#12

From the other side of the consultation, briefly.

Vendor communication red flags for compounded supply:

  • Won't provide COA before purchase — walk away
  • Claims "100% pure" without analytical data — unrealistic
  • No physical address or phone number — accountability matters
  • Pushes you to buy more than you need — pressure tactics
  • Won't answer questions about their compounding process — transparency is key
  • Payment only via crypto or wire transfer — legitimate pharmacies accept cards

A legitimate compounding pharmacy operates like a healthcare business, not a gray market dealer.

34 7Dr.Martinez, mike_mod, SarahChen_PharmD and 31 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jul 10, 2024 at 9:32 AM#13
james_edin said:
SURMOUNT-1 landed around 20.9% mean weight loss at 15mg over 72 weeks, against roughly 15% for semaglutide 2.4mg in STEP 1.

I read this differently from james_edin, on substance rather than tone. The "tirzepatide is simply better" summary irritates me. It is better on mean weight loss, and the cardiovascular outcome evidence is far thinner than semaglutide's. If the reason for treating is cardiovascular risk rather than weight, the evidence base points the other way.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

35 8LibrarianMeg, bri_stats, pete_manc_UK and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Jul 10, 2024 at 3:22 PM#14
nick_newbie said:
The shortage clause is the answer to the second question and it is a subtraction rather than an addition.

Regarding compounded supply compounding legality: compounding pharmacies can legally produce semaglutide and tirzepatide while these drugs remain on the FDA shortage list. If/when the shortage resolves, the legal landscape may change.

Stay informed. The FDA shortage list is updated regularly. Current status as of my last check: semaglutide still in shortage, tirzepatide removed from shortage list. This directly impacts compounding availability.

36 9TomFromTexas, mike.trainer_LA, sarah_nash92 and 33 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 10, 2024 at 9:13 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

37 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 34 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register